. Enhancing ESC self-renewal leads to decreased glutamine anaplerosis. a,b, Immunoblot of phospho-STAT3 and total STAT3 (a) or qRT-PCR of STAT3-target genes and other key pluripotency genes (b) in ESCs expressing GCSF-activated LIF receptor transgene cultured with or without GCSF. c, Quantification of glutamate pools in ESCs expressing GCSF-activated LIF receptor transgene cultured with or without GCSF in medium containing [U-13 C]glucose and following 4 h of glutamine withdrawal. Quantification of pools either labeled or not labeled by glucose-derived [U-13 C] are indicated. d,e, Immunoblot of Nanog and Klf4 (d) or qRT-PCR of key pluripotency genes (e) in ESCs expressing empty vector, Klf4, or Nanog. f, Schematic depicting how metabolism of uniformly-labeled glucose ([U-13 C]glucose) via pyruvate carboxylase generates metabolites associated with the TCA cycle. Colored circles represent 13 C-labeled carbons. g,h, Fractional m+3 labeling of aspartate (Asp), malate (Mal) and fumarate (Fum) in ESCs expressing GCSF-activated LIF receptor transgene cultured with or without GCSF (g) or ESCs expressing empty vector, Klf4 or Nanog (h) cultured in medium containing [U-13 C]glucose. i,j, Population doublings of ESCs expressing GCSF-activated LIF receptor transgene cultured with or without GCSF (i) or ESCs expressing empty vector, Klf4 or Nanog (j) during 48 h of culture in glutamine-replete medium. k, Quantification of the αKG/succinate ratio in Nanog Low, Nanog Medium, and Nanog High populations. Nanog-GFP ESCs cultured in S/L medium were sorted based on GFP expression; the top 10%, bottom 10%, and median 10% populations were sorted and cultured for 48 h prior to harvesting for metabolite extraction and analysis. P values were calculated by unpaired, two-sided Student's t-test (b,c,g,i) or one-way ANOVA with Sidak's multiple comparisons post-test (e,h,j,k), relative to control ESCs (b,c,e,g,h,i,j) or Nanog Low ESCs (k). Data are presented as the mean ± s.d. of n=3 biologically independent samples from a representative experiment (b,c,g,h,i,j,k). Experiments were repeated 2 times with similar results (a,d). Molecular weight marker (in kDa) is shown (a,d).
. Glutamine is a major source of TCA cycle anaplerosis in ESCs. a, Population doublings of ESCs cultured with or without glutamine. b, Viability of ESCs cultured for 24 h with or without glutamine and 4 mM cell-permeable dimethyl-α ketoglutarate (DM-αKG) . c, Viability of Nanog High, Nanog Medium, and Nanog Low ESCs 48 h after sorting based on Nanog-GFP expression and deprived of glutamine for the final 24 h. d, Median Nanog-GFP expression in Nanog High and Nanog Low ESCs (described in Fig. 2a ) 72 h after sorting based on Nanog-GFP expression and deprived of glutamine for the final 24 h. e,f, Population doublings of ESCs during 48 h of culture in medium containing glutamine with the following additions as noted: 4 mM DM-αKG, 4 mM dimethyl-succinate (DM-succ), 2 mM methyl-pyruvate (Me-pyruvate) or 1 mM methionine sulfoximine (MSO). g,h, Relative abundance of TCA cycle metabolites following 8 h of glutamine withdrawal in ESCs expressing GCSF-activated LIF receptor transgene cultured with or without GCSF (g) or ESCs expressing empty vector, Klf4 or Nanog (h) relative to control or empty vector ESCs cultured in glutamine-replete medium. i,j, Intracellular αKG pools in ESCs expressing GCSF-activated LIF receptor transgene cultured with or without GCSF (i) or ESCs expressing empty vector, Klf4 or Nanog (j) cultured in medium lacking glutamine for 4 h. k, Median Nanog-GFP expression in ESCs expressing GCSF-activated LIF receptor transgene cultured with or without GCSF grown in the presence or absence of glutamine for 48 h. P values were calculated by unpaired, two-sided Student's ttest (a,g,i,k) or one-way ANOVA with Sidak's multiple comparisons post-test (b,c,d,h,j), relative to control ESCs
Supplementary Figure 3. Pulsed glutamine withdrawal selects for ESCs with durable self-renewal. a,
Quantification of nuclear Nanog (left) and Oct4 (right) immunofluorescence in ESCs cultured in either S/L (grey) or S/L+2i (blue) medium. Dashed line denotes an estimated threshold for "Nanog low" and "Oct4 low" cells, respectively, defined as cells one standard deviation below the mean values of the control population (here, S/L). b, Nanog immunofluorescence in ESCs cultured in the absence of glutamine for the indicated times. Dashed lines denote estimated thresholds for "Nanog low" and "Nanog high" cells, defined as cells 0.25 standard deviations below and one standard deviation above the mean values of the control population, respectively. c, Nanog-GFP expression in ESCs subjected to 24 h of glutamine withdrawal (Withdrawal), subjected to 24 h of glutamine withdrawal followed by 24 h of culture in glutamine-replete medium (Pulse -Q), or maintained continuously in glutamine-replete medium (Ctrl). d, Teratoma formation from ESCs grown either in glutamine-replete S/L medium (Control), subjected to 24 h of glutamine deprivation followed by recovery in medium containing glutamine for 24 h (Pulse -Q), or adapted to S/L+2i medium for 3 passages (2i). Representative images of haematoxylin and eosin staining revealing differentiation into ectoderm, mesoderm, and endoderm-derived tissue. Scale bar, 50 µm. Experiment was performed two independent times with n=7 total mice for Control and +2i groups and n=5 total mice for Pulse -Q. e, Nanog-GFP expression in ESCs subjected to 24 h of glutamine withdrawal (Pulse -Q) or 2i (Pulse 2i) and then recovered with glutamine-replete medium for 24 h, or maintained for 48 h in either medium containing glutamine (Control) or medium containing glutamine and 2i (2i continuous). f, Expression of Nanog-GFP in ESCs exposed to 24 h of glutamine withdrawal (Pulse -Q) or 4 mM DM-αKG (Pulse αKG) and then recovered with glutamine-replete medium for 24 h, or maintained for 48 h in medium containing glutamine (Control). g, Alkaline phosphatase (AP) staining of colony formation assays in which ESCs were subjected to 24 h of glutamine withdrawal (Pulse -Q) or 4 mM DM-αKG (Pulse αKG) and then recovered with glutamine-replete medium for 24 h, or maintained for 48 h in medium containing glutamine (Control), prior to plating at single cell density. One representative well of a six-well plate is shown. h, Nanog-GFP expression in ESCs subjected to 24 h of glutamine withdrawal (Pulse -Q) or maintained in standard glutamine-replete medium (Control) in the presence or absence of methionine sulfoximine (MSO, 1 mM) or the H3K27me3 demethylase inhibitor GSK-J4 (5 µM) and then recovered with glutamine-replete, inhibitor-free medium for 24 h. i, AP staining of colony formation assays in which ESCs were subjected to 24 h of glutamine withdrawal (Pulse -Q) or maintained in standard glutamine-replete medium (Control) in the presence or absence of GSK-J4 and then recovered with glutamine-replete, inhibitor-free medium for 24 h prior to plating at single cell density. One representative well of a six-well plate is shown. j, Nanog-GFP expression in ESCs subjected to withdrawal of either glutamine, glucose, or both glutamine and glucose for 24 h and then recovered with glutamine and glucose-replete medium for 24 h or maintained in glutamine and glucose-replete medium as indicated. P values were calculated by one-way ANOVA with Sidak's multiple comparisons post-test of "2i continuous" ESCs relative to "Pulse 2i" ESCs (e) or relative to control ESCs (e,f,j). Data are presented as the mean ± s.d. of n=3 biologically independent samples from a representative experiment (e,f,j), or as >10,000 cells pooled from n=3 biologically independent samples from a representative experiment (a,b). Experiments were repeated two times with similar results (c,d,g,i) .
